Modifier genes and sickle cell anemia
Authors:
- Martin H SteinbergMSMartin H Steinberg
- Adeboye H AdewoyeAAAdeboye H Adewoye
- 1 May 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 13 (3) , 131-136
Abstract
With the completion of the human genome project and HapMap, previously unknown genetic polymorphisms associated with disease have been observed. This review highlights genetic polymorphisms that have provided insight into the pathophysiology underlying the many phenotypes of sickle cell disease. The phenotypes of sickle cell disease are likely to be modulated by polymorphisms in genes that are involved in inflammation, cell-cell interaction, and nitric oxide biology. Case-control studies are beginning to define the relationships between single-nucleotide polymorphisms in candidate genes and the many subphenotypes of sickle cell anemia. A common theme emerging from these studies is that single-nucleotide polymorphisms in genes of the transforming growth factor-beta/bone morphogenetic protein and a few other genes such as Klotho are associated with several subphenotypes of sickle cell disease. Genomic medicine is merging with clinical practice as our understanding of the structure and variability of the human genome increases. Patients with diseases caused by identical mutations in a single gene - sickle cell anemia is a prime example - can have clinical courses very different from one another, and when environmental influences are removed the phenotypic heterogeneity of mendelian single-gene disorders is best explained by single-nucleotide polymorphisms in genes that modulate the disease phenotype. As this field expands, insights will be gained into complex epistatic factors that influence the clinical presentation of sickle cell disease, enabling physicians to better predict and manage the many complications of this disease.Keywords
This publication has 51 references indexed in Scilit:
- Negative epistasis between the malaria-protective effects of α+-thalassemia and the sickle cell traitNature Genetics, 2005
- New Insights Into the Genetic Regulation of Intestinal Cholesterol AbsorptionGastroenterology, 2005
- Polymorphism of the human platelet antigen‐5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemiaVox Sanguinis, 2004
- Angiotensinogen gene associated polymorphisms and risk of stroke in sickle cell anemia: Additional data supporting an associationAmerican Journal of Hematology, 2004
- Gender‐specific disease modification by NOS3British Journal of Haematology, 2004
- Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell DiseaseNew England Journal of Medicine, 2004
- UDP‐glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemiaClinical Genetics, 2003
- Stroke risk in siblings with sickle cell anemiaBlood, 2003
- Evidence of Genetic Interaction between the β-Globin Complex and Chromosome 8q in the Expression of Fetal HemoglobinThe American Journal of Human Genetics, 2002
- Cloning and Characterization of the Human and Mouse PDE7B, a Novel cAMP-Specific Cyclic Nucleotide PhosphodiesteraseBiochemical and Biophysical Research Communications, 2000